Skip to menu Skip to content Skip to footer
Dr Mark Effron
Dr

Mark Effron

Email: 

Overview

Availability

Dr Mark Effron is:
Available for supervision

Works

Search Professor Mark Effron’s works on UQ eSpace

169 works between 1978 and 2025

21 - 40 of 169 works

2022

Journal Article

To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years

Rizk, John G., Gupta, Aashish, Lazo, Jose G., Sardar, Partha, Henry, Brandon Michael, Lavie, Carl J. and Effron, Mark B. (2022). To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years. Seminars in Thrombosis and Hemostasis, 49 (01), 062-072. doi: 10.1055/s-0042-1744302

To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years

2021

Journal Article

Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

Lawler, Patrick R., Goligher, Ewan C., Berger, Jeffrey S., Neal, Matthew D., McVerry, Bryan J., Nicolau, Jose C., Gong, Michelle N., Carrier, Marc, Rosenson, Robert S., Reynolds, Harmony R., Turgeon, Alexis F., Escobedo, Jorge, Huang, David T., Bradbury, Charlotte A., Houston, Brett L., Kornblith, Lucy Z., Kumar, Anand, Kahn, Susan R., Cushman, Mary, McQuilten, Zoe, Slutsky, Arthur S., Kim, Keri S., Gordon, Anthony C., Kirwan, Bridget-Anne, Brooks, Maria M., Higgins, Alisa M., Lewis, Roger J., Lorenzi, Elizabeth, Berry, Scott M. ... The ATTACC, ACTIV-4a, and REMAP-CAP Investigators (2021). Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19. New England Journal of Medicine, 385 (9), 790-802. doi: 10.1056/NEJMoa2105911

Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

2021

Journal Article

Therapeutic anticoagulation with heparin in critically ill patients with covid-19

Goligher, Ewan C., Bradbury, Charlotte A., McVerry, Bryan J., Lawler, Patrick R., Berger, Jeffrey S., Gong, Michelle N., Carrier, Marc, Reynolds, Harmony R., Kumar, Anand, Turgeon, Alexis F., Kornblith, Lucy Z., Kahn, Susan R., Marshall, John C., Kim, Keri S., Houston, Brett L., Derde, Lennie P.G., Cushman, Mary, Tritschler, Tobias, Angus, Derek C., Godoy, Lucas C., McQuilten, Zoe, Kirwan, Bridget-Anne, Farkouh, Michael E., Brooks, Maria M., Lewis, Roger J., Berry, Lindsay R., Lorenzi, Elizabeth, Gordon, Anthony C., Berry, Scott M. ... The REMAP-CAP, ACTIV-4a, and ATTACC Investigators (2021). Therapeutic anticoagulation with heparin in critically ill patients with covid-19. New England Journal of Medicine, 385 (9), 777-789. doi: 10.1056/NEJMoa2103417

Therapeutic anticoagulation with heparin in critically ill patients with covid-19

2021

Journal Article

Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial

Kochar, Ajar, Summers, Mary B., Benziger, Catherine P., Marquis-Gravel, Guillaume, DeWalt, Darren A., Pepine, Carl J., Gupta, Kamal, Bradley, Steven M., Dodson, John A., Lampert, Brent C., Robertson, Holly, Polonsky, Tamar S., Jones, W. Schuyler and Effron, Mark B (2021). Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial. Clinical Trials, 18 (4) 1740774520988838, 449-456. doi: 10.1177/1740774520988838

Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial

2021

Journal Article

Comparative effectiveness of aspirin dosing in cardiovascular disease

Jones, W. Schuyler, Mulder, Hillary, Wruck, Lisa M., Pencina, Michael J., Kripalani, Sunil, Muñoz, Daniel, Crenshaw, David L., Effron, Mark B., Re, Richard N., Gupta, Kamal, David Anderson, R., Pepine, Carl J., Handberg, Eileen M., Manning, Brittney R., Jain, Sandeep K., Girotra, Saket, Riley, Danielle, DeWalt, Darren A., Whittle, Jeff, Goldberg, Ythan H., Roger, Veronique L., Hess, Rachel, Benziger, Catherine P., Farrehi, Peter, Zhou, Li, Ford, Daniel E., Haynes, Kevin, VanWormer, Jeffrey J., Knowlton, Kirk U. ... for the ADAPTABLE Team (2021). Comparative effectiveness of aspirin dosing in cardiovascular disease. New England Journal of Medicine, 384 (21), 1981-1990. doi: 10.1056/NEJMoa2102137

Comparative effectiveness of aspirin dosing in cardiovascular disease

2020

Journal Article

Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study

Chandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Moalem, Kamilia, Kini, Annapoorna S., Rao, Sunil V., Weintraub, William, Henry, Timothy D., Vogel, Birgit, Ge, Zhen, Muhlestein, Joseph B., Weiss, Sandra, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Claessen, Bimmer E., Keller, Stuart, Baker, Brian A., Effron, Mark B., Pocock, Stuart, Dangas, George, Kapadia, Samir and Mehran, Roxana (2020). Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study. Clinical Research in Cardiology, 109 (6), 725-734. doi: 10.1007/s00392-019-01561-4

Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study

2020

Journal Article

Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry

Chandiramani, Rishi, Chen, Huazhen, Aoi, Shunsuke, Giustino, Gennaro, Claessen, Bimmer, Sartori, Samantha, Aquino, Melissa, Sorrentino, Sabato, Cao, Davide, Goel, Ridhima, Kini, Annapoorna, Rao, Sunil, Weintraub, William, Henry, Timothy D., Kapadia, Samir, DeFranco, Anthony, Muhlestein, Joseph B., Toma, Catalin, Effron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Baber, Usman and Mehran, Roxana (2020). Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry. Catheterization and Cardiovascular Interventions, 95 (5) ccd.28369, 885-892. doi: 10.1002/ccd.28369

Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry

2020

Journal Article

Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

Marquis-Gravel, Guillaume, Roe, Matthew T., Robertson, Holly R., Harrington, Robert A., Pencina, Michael J., Berdan, Lisa G., Hammill, Bradley G., Faulkner, Madelaine, Muñoz, Daniel, Fonarow, Gregg C., Nallamothu, Brahmajee K., Fintel, Dan J., Ford, Daniel E., Zhou, Li, Daugherty, Sarah E., Nauman, Elizabeth, Kraschnewski, Jennifer, Ahmad, Faraz S., Benziger, Catherine P., Haynes, Kevin, Merritt, J. Greg, Metkus, Thomas, Kripalani, Sunil, Gupta, Kamal, Shah, Raj C., McClay, James C., Re, Richard N., Geary, Carol, Lampert, Brent C. ... Jones, W. Schuyler (2020). Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiology, 5 (5) 0116, 598-607. doi: 10.1001/jamacardio.2020.0116

Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial

2019

Journal Article

Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: insights from the TRANSLATE ACS study

Ibrahim, Homam, Kaltenbach, Lisa A., Hess, Connie N., Recchia, Tammy, Effron, Mark B., Stone, Gregg W. and Wang, Tracy Y. (2019). Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: insights from the TRANSLATE ACS study. Catheterization and Cardiovascular Interventions, 93 (4), E204-E210. doi: 10.1002/ccd.27816

Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: insights from the TRANSLATE ACS study

2019

Journal Article

The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry

Ge, Zhen, Baber, Usman, Claessen, Bimmer E., Farhan, Serdar, Chandrasekhar, Jaya, Li, Shawn X., Sartori, Samantha, Kini, Annapoorna S., Rao, Sunil V., Weiss, Sandra, Henry, Timothy D., Vogel, Birgit, Sorrentino, Sabato, Faggioni, Michela, Kapadia, Samir, Muhlestein, Brent, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Effron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Dangas, George and Mehran, Roxana (2019). The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry. Catheterization and Cardiovascular Interventions, 93 (3), E112-E119. doi: 10.1002/ccd.27860

The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry

2019

Journal Article

Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes

Faggioni, Michela, Baber, Usman, Chandrasekhar, Jaya, Sartori, Samantha, Weintraub, William, Rao, Sunil V., Vogel, Birgit, Claessen, Bimmer, Kini, Annapoorna, Effron, Mark, Ge, Zhen, Keller, Stuart, Strauss, Craig, Snyder, Clayton, Toma, Catalin, Weiss, Sandra, Aquino, Melissa, Baker, Brian, Defranco, Anthony, Bansilal, Sameer, Muhlestein, Brent, Kapadia, Samir, Pocock, Stuart, Poddar, Kanhaiya L., Henry, Timothy D. and Mehran, Roxana (2019). Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes. Catheterization and Cardiovascular Interventions, 94 (1), 53-60. doi: 10.1002/ccd.28033

Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes

2019

Book Chapter

Advances in Cardiovascular Diagnostics Use of Cardiac Biomarkers in Clinical Research and Care of the Patient

Effron, Mark B. and Khan, Zahoor (2019). Advances in Cardiovascular Diagnostics Use of Cardiac Biomarkers in Clinical Research and Care of the Patient. Handbook of Biomarkers and Precision Medicine. (pp. 501-513) edited by Carini, C., Fidock, M. and VanGool, A.. Boca Raton, FL United States: CRC Press.

Advances in Cardiovascular Diagnostics Use of Cardiac Biomarkers in Clinical Research and Care of the Patient

2018

Journal Article

Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study

Chandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna S., Rao, Sunil, Weintraub, William, Henry, Timothy D., Farhan, Serdar, Vogel, Birgit, Sorrentino, Sabato, Ge, Zhen, Kapadia, Samir, Muhlestein, Joseph B., Weiss, Sandra, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Effron, Mark B., Keller, Stuart, Baker, Brian A., Pocock, Stuart, Dangas, George and Mehran, Roxana (2018). Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study. Canadian Journal of Cardiology, 34 (3), 319-329. doi: 10.1016/j.cjca.2017.12.023

Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study

2018

Journal Article

The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS study

Effron, Mark B., Wang, Tracy Y., Fonarow, Gregg C., Henry, Timothy D., Zettler, Marjorie E., Baker, Brian A., McCoy, Lisa A. and Peterson, Eric D. (2018). The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS study. Catheterization and Cardiovascular Interventions, 91 (2), 242-250. doi: 10.1002/ccd.27145

The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: insights from the TRANSLATE-ACS study

2018

Journal Article

Antiplatelet therapy changes for patients with myocardial infarction with recurrent ischemic events: Insights into contemporary practice from the TRANSLATE-ACS (treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary syndrome) study

Fanaroff, Alexander C., Kaltenbach, Lisa A., Peterson, Eric D., Akhter, Mohammed W., Effron, Mark B., Henry, Timothy D. and Wang, Tracy Y. (2018). Antiplatelet therapy changes for patients with myocardial infarction with recurrent ischemic events: Insights into contemporary practice from the TRANSLATE-ACS (treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary syndrome) study. Journal of the American Heart Association, 7 (4) e007982. doi: 10.1161/JAHA.117.007982

Antiplatelet therapy changes for patients with myocardial infarction with recurrent ischemic events: Insights into contemporary practice from the TRANSLATE-ACS (treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary syndrome) study

2018

Journal Article

The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?

Effron, Mark B. and Gibson, C. Michael (2018). The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?. Progress in Cardiovascular Diseases, 60 (4-5), 457-459. doi: 10.1016/j.pcad.2018.01.011

The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease – Where Is the Moon Now?

2018

Journal Article

Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience

Effron, Mark B. and Gibson, C. Michael (2018). Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience. Progress in Cardiovascular Diseases, 60 (4-5), 531-536. doi: 10.1016/j.pcad.2018.01.010

Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience

2017

Journal Article

One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database

Effron, Mark B., Nair, Kavita V., Molife, Cliff, Keller, Stuart Y., Page, Robert L., Simeone, Jason C., Murphy, Brian, Nordstrom, Beth L., Zhu, Yajun, McCollam, Patrick L. and Vetrovec, George W. (2017). One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database. American Journal of Cardiovascular Drugs , 18 (2), 129-141. doi: 10.1007/s40256-017-0255-y

One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database

2017

Journal Article

Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study

Baber, Usman, Chandrasekhar, Jaya, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna S., Kapadia, Samir, Weintraub, William, Muhlestein, Joseph B., Vogel, Birgit, Faggioni, Michela, Farhan, Serdar, Weiss, Sandra, Strauss, Craig, Toma, Catalin, DeFranco, Anthony, Baker, Brian A., Keller, Stuart, Effron, Mark B., Henry, Timothy D., Rao, Sunil, Pocock, Stuart, Dangas, George and Mehran, Roxana (2017). Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. JACC: Cardiovascular Interventions, 10 (20), 2017-2025. doi: 10.1016/j.jcin.2017.02.047

Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study

2017

Journal Article

Multivessel versus culprit vessel-only percutaneous coronary intervention among patients with acute myocardial infarction: Insights from the TRANSLATE-ACS observational study

Ibrahim, Homam, Sharma, Praneet K., Cohen, David J., Fonarow, Gregg C., Kaltenbach, Lisa A., Effron, Mark B., Zettler, Marjorie E., Peterson, Eric D. and Wang, Tracy Y. (2017). Multivessel versus culprit vessel-only percutaneous coronary intervention among patients with acute myocardial infarction: Insights from the TRANSLATE-ACS observational study. Journal of the American Heart Association, 6 (10) e006343. doi: 10.1161/JAHA.117.006343

Multivessel versus culprit vessel-only percutaneous coronary intervention among patients with acute myocardial infarction: Insights from the TRANSLATE-ACS observational study

Supervision

Availability

Dr Mark Effron is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Mark Effron's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au